Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Since she enrolled in a clinical trial at MSK to treat her low-grade serous ovarian cancer, Ellen Coopersmith has a new outlook on life. The first drug for a rare and difficult-to-treat type of ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Maureen Sideris, seated, with her sister Marion, receiving the 8th of 9 immunotherapy infusions during successful treatment for early-stage gastroesophageal junction cancer at Memorial Sloan Kettering ...

Dr. William Tap led the development of vimseltinib for tenosynovial giant cell tumor. The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza TM) for adult patients with a rare ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

A team led by surgeon-scientist Dr. Vinod Balachandran identified the molecular pathway involved in the formation of tertiary lymphoid structures. Therapeutically targeting this pathway could ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

A Potential New Test for Lung Cancer: The Noninvasive E-Nose Detecting lung cancer as early as possible improves outcomes for patients, but only 1 in 5 patients who should be screened with a low-dose ...

Descubra por qué las personas con riesgo de cáncer pulmonar no se están realizando la prueba de detección y por qué deberían hacerlo.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Mushrooms have always had an aura of special power about them. People all over the world have used them as medicine in the treatment of infection, lung disease, cancer, and other conditions for ...